Skip to main content

Table 1 Antibacterial resistance of MRSA isolates, 1994–2004.

From: Antibacterial resistance and their genetic location in MRSA isolated in Kuwait hospitals, 1994-2004

Year Antibacterial resistance in MRSA (%)
  # Gm Km Sm Em Cm Tet Tp Cip Fa Rf MupH Cd*
1994 342 98 100 100 66 25 94 86 53 22 1.0 ND 100
1995 298 95 98 100 89 25 92 87 23 45 1.4 ND 98
1996 421 100 100 100 68 44 94 93 41 32 3.0 6.0 100
1997 245 94 99 99 81 23 95 75 72 57 5.0 17 97
1998 329 88 95 77 74 21 92 61 63 75 3.0 24 94
1999 336 84 92 92 69 4.0 93 38 79 89 2.0 28 94
2000 542 86 95 94 76 3.0 89 34 72 81 8.0 22 98
2001 533 77 88 89 86 2.0 79 37 81 88 1.0 2.7 94
2002 883 85 95 89 88 4.0 90 16 96 90 5.0 3.0 93
2003 785 77 88 89 86 4.0 88 17 88 85 1.0 1.0 91
2004 930 81 89 86 88 2.0 88 27 92 92 4.7 4.7 89
  1. Abbreviations: #, number of isolates Gm, gentamicin, Km, kanamycin, Sm, streptomycin, Em, erythromycin, Cm, chloramphenicol, Tet, tetracycline, Tp, trimethoprim, Cip, ciprofloxacin, Fa, fusidic acid, Rf, rifampicin, MupH, high-level mupirocin resistance, Cd, cadmium acetate, also resistant to mercuric chloride, propamidine isethionate and ethidium bromide, ND, not detected